$QNRX

$7.49▲ +8.2% YTD

7 SEC 13D/G filings tracked · Last updated Sep 22, 2026

Filing History

QNRX ▲ +8.2% - Quoin Pharmaceuticals, Ltd.

CP $7.49▲ +8.2%Sep 22, 2026 · ThinkSabio Blog

$QNRX - Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome…

News

QNRX ▼ -1.0% - Quoin Pharmaceuticals, Ltd.

CP $6.90▲ -1.0%Sep 10, 2026 · ThinkSabio Blog

$QNRX - Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daug…

News

QNRX ▼ -0.8% - Quoin Pharmaceuticals, Ltd.

CP $7.20▲ -0.8%Sep 8, 2026 · ThinkSabio Blog

$QNRX - CORRECTION -- Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome…

News

QNRX ▲ +1.4% - Quoin Pharmaceuticals, Ltd.

CP $7.36▲ +1.4%Sep 8, 2026 · ThinkSabio Blog

$QNRX - Quoin Pharmaceuticals Announces FDA Grants Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome…

News

QNRX ▲ +58.9% - Quoin Pharmaceuticals, Ltd.

CP $8.20▲ +58.9%Aug 28, 2026 · ThinkSabio Blog

$QNRX $50M PIPE at $4.88/ADS…

News

QNRX ▲ +57.0% - Quoin Pharmaceuticals, Ltd.

CP $8.10▲ +57.0%Aug 28, 2026 · ThinkSabio Blog

$QNRX - Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million…

News

QNRX ▲ +57.0% - Quoin Pharmaceuticals, Ltd.

CP $8.10▲ +57.0%Aug 28, 2026 · ThinkSabio Blog

$QNRX - Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome…